Article Text

Download PDFPDF

Exacerbations in cystic fibrosis: 4 · Non-cystic fibrosis bronchiectasis
  1. A B Chang1,
  2. D Bilton2
  1. 1
    Department of Respiratory Medicine, Royal Children’s Hospital and Child Health Division, Menzies School of Health Research, Charles Darwin University, Brisbane, Australia
  2. 2
    Lung Defence Unit, Papworth Hospital NHS Trust, Cambridge, UK
  1. Dr A B Chang, Department of Respiratory Medicine, Royal Children’s Hospital, Herston Road, Brisbane, Queensland 4029, Australia; annechang{at}


Bronchiectasis unrelated to cystic fibrosis (CF) is increasingly recognised as an important and major primary respiratory disease in developing countries. In affluent countries, bronchiectasis is also increasingly recognised in subsections of communities (such as indigenous peoples) as well as a co-existent disease/co-morbidity and disease modifier in respiratory diseases such as chronic obstructive pulmonary disease. The epidemiology, pathogenesis, prevention and management of exacerbations of non-CF bronchiectasis are reviewed. There are few data on all aspects of exacerbations in bronchiectasis. Some of the management issues are common to non-CF and CF bronchiectasis, but it would be unwise to extrapolate from CF studies to non-CF bronchiectasis. In some situations this may be harmful.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding: ABC is funded by the Australian National Health Medical Research Council and the Royal Children’s Hospital Foundation.

  • Competing interests: None.